Recent advances in the understanding and management of mucormycosis [version 1; referees: 2 approved]

Benoit Pilmis; Alexandre Alanio; Olivier Lortholary; Fanny Lanternier

doi:10.12688/f1000research.15081.1

F1000Research (Sep 2018)

Recent advances in the understanding and management of mucormycosis [version 1; referees: 2 approved]

Benoit Pilmis,
Alexandre Alanio,
Olivier Lortholary,
Fanny Lanternier

Affiliations

Benoit Pilmis: Paris Descartes University, Sorbonne Paris Cité, Infectious Diseases Unit, Necker-Enfants Malades University Hospital, AP-HP, Imagine Institute, Paris, France
Alexandre Alanio: Université Paris Diderot, Sorbonne Paris Cité, Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Groupe Hospitalier Lariboisière, Saint-Louis, Fernand Widal, AP-HP, Paris, France
Olivier Lortholary: Paris Descartes University, Sorbonne Paris Cité, Infectious Diseases Unit, Necker-Enfants Malades University Hospital, AP-HP, Imagine Institute, Paris, France
Fanny Lanternier: Paris Descartes University, Sorbonne Paris Cité, Infectious Diseases Unit, Necker-Enfants Malades University Hospital, AP-HP, Imagine Institute, Paris, France

DOI: https://doi.org/10.12688/f1000research.15081.1
Journal volume & issue: Vol. 7

Abstract

Read online

Mucormycoses were difficult-to-manage infections owing to limited diagnostic tools and therapeutic options. We review here advances in pathology understanding, diagnostic tools including computed tomography, and serum polymerase chain reaction and therapeutic options.

Published in F1000Research

ISSN: 2046-1402 (Online)
Publisher: F1000 Research Ltd
Country of publisher: United Kingdom
LCC subjects: Medicine; Science
Website: https://f1000research.com

About the journal